ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08814
0,06%
Bitcoin
67.069,27
1,37%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Inhibitor Therapeutics Inc (QB) (INTI)

  7. Inhibitor Therapeutics Inc (QB) (INTI) News

INTI

Inhibitor Therapeutics (QB) (INTI)

Inhibitor Therapeutics Inc (QB)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:INTI
DatumZeitQuelleÜberschriftSymbolFirma
16/05/202419h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INTIInhibitor Therapeutics Inc (QB)
16/05/202419h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INTIInhibitor Therapeutics Inc (QB)
16/05/202419h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INTIInhibitor Therapeutics Inc (QB)
16/05/202419h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INTIInhibitor Therapeutics Inc (QB)
16/05/202419h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INTIInhibitor Therapeutics Inc (QB)
13/05/202415h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:INTIInhibitor Therapeutics Inc (QB)
14/12/202312h02Edgar (US Regulatory)Form 8-K - Current reportUSOTC:INTIInhibitor Therapeutics Inc (QB)
18/10/202315h54Edgar (US Regulatory)Form 8-K - Current reportUSOTC:INTIInhibitor Therapeutics Inc (QB)
29/08/202321h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INTIInhibitor Therapeutics Inc (QB)
29/08/202320h42Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:INTIInhibitor Therapeutics Inc (QB)
29/08/202320h33Edgar (US Regulatory)Form 8-K - Current reportUSOTC:INTIInhibitor Therapeutics Inc (QB)
11/08/202315h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:INTIInhibitor Therapeutics Inc (QB)
31/05/202322h31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:INTIInhibitor Therapeutics Inc (QB)
23/05/202318h50Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:INTIInhibitor Therapeutics Inc (QB)
22/05/202321h45Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:INTIInhibitor Therapeutics Inc (QB)
18/05/202312h02Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:INTIInhibitor Therapeutics Inc (QB)
18/05/202301h47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:INTIInhibitor Therapeutics Inc (QB)
18/05/202301h11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:INTIInhibitor Therapeutics Inc (QB)
18/05/202301h10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:INTIInhibitor Therapeutics Inc (QB)
15/05/202315h04Edgar (US Regulatory)Quarterly Report (10-q)USOTC:INTIInhibitor Therapeutics Inc (QB)
19/12/202223h01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:INTIInhibitor Therapeutics Inc (QB)
14/11/202222h39Edgar (US Regulatory)Quarterly Report (10-q)USOTC:INTIInhibitor Therapeutics Inc (QB)
15/09/202223h07Edgar (US Regulatory)Current Report Filing (8-k)USOTC:INTIInhibitor Therapeutics Inc (QB)
13/05/202215h02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:INTIInhibitor Therapeutics Inc (QB)
30/03/202215h02Edgar (US Regulatory)Annual Report (10-k)USOTC:INTIInhibitor Therapeutics Inc (QB)
12/11/202115h02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:INTIInhibitor Therapeutics Inc (QB)
14/05/202115h02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:INTIInhibitor Therapeutics Inc (QB)
26/03/202114h03Edgar (US Regulatory)Annual Report (10-k)USOTC:INTIInhibitor Therapeutics Inc (QB)
19/01/202119h51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:INTIInhibitor Therapeutics Inc (QB)
06/01/202122h31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:INTIInhibitor Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:INTI

Kürzlich von Ihnen besucht

NASDAQ
KRSSX
Real Estate Select Trust...
LSE
0GDO
Unigrowth Investments Pu...
BIT
UC101H
Unicredit Bank
USOTC
TPRFF
Aris Mining (QX)
TG
458
Q2 Metals
TG
HEMP
Deutsche Cannabis
TG
AJP
Artmarket.com
TSXV
FWZ
Fireweed Metals
UPBT
POLYKRW
Polymath
TG
AY1
Alliant Energy
NASDAQ
GPCOW
Golden Path Acquisition
NASDAQ
FKGFOX
Dow Jones Global Titans ...
TG
JDE
JDE Peets NV
TG
CVZ
Vermilion Energy
AMEX
WUCT
ETRACS Whitney US Critic...
NASDAQ
FEPTHX
Diversified Assets Portf...
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten